KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Return on Sales (2016 - 2026)

Bio-Rad Laboratories has reported Return on Sales over the past 18 years, most recently at 0.01% for Q1 2026.

  • Quarterly Return on Sales fell 1.0% to 0.01% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, up 1.0% year-over-year, with the annual reading at 0.0% for FY2025, 1.0% up from the prior year.
  • Return on Sales was 0.01% for Q1 2026 at Bio-Rad Laboratories, down from 0.01% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.01% in Q4 2022 and troughed at 0.05% in Q1 2022.
  • The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.01%.
  • Year-over-year, Return on Sales dropped -6bps in 2022 and then rose 5bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.01% in 2022, then crashed by -55bps to 0.01% in 2023, then plummeted by -309bps to 0.01% in 2024, then soared by 197bps to 0.01% in 2025, then plummeted by -186bps to 0.01% in 2026.
  • Per Business Quant, the three most recent readings for BIO's Return on Sales are 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).